Moneycontrol PRO
Open App
Upcoming Event: Finterest EduTech Technical Analysis Programme in Oct, book your seats.
you are here: HomeNewsIndia

COVID-19 Vaccine Tracker: Over 59.08 lakh jabs on November 8

Scientists have developed a new protein-based vaccine candidate for COVID-19 that they say is much easier to produce and does not need refrigeration.

November 09, 2021 / 09:33 AM IST
A healthcare worker gives a dose of the COVISHIELD vaccine against the coronavirus disease (COVID-19), manufactured by Serum Institute of India, to a farmer in his field, during a door-to-door vaccination drive in Banaskantha district in the western state of Gujarat. (Representative image: Reuters)

A healthcare worker gives a dose of the COVISHIELD vaccine against the coronavirus disease (COVID-19), manufactured by Serum Institute of India, to a farmer in his field, during a door-to-door vaccination drive in Banaskantha district in the western state of Gujarat. (Representative image: Reuters)

India has administered more than 59.08 lakh COVID-19 vaccine doses in the last 24 hours, taking the vaccination count beyond 109.08 crore, according to the Union Health Ministry update on November 9.

On the 297th day of the nationwide vaccination drive, over 17.71 lakh people received their first shot and 41.36 lakh their second dose.

The vaccination drive accelerated over the last few weeks. It took the country 85 days to give the first 10 crore doses, the next 10 crore took 45 days and, in another 29 days, India touched the 30-crore mark.

By the following 24 days, the count reached 40 crore and crossed the 50-crore mark after 20 days on August 6. By September 13, 75 crore vaccine doses were given. The biggest jump, however, came on September 17, when more than 2.1 crore shots were given in one day.

On October 21, India scripted history with cumulative COVID-19 vaccine doses administered in the country surpassing the 100-crore milestone.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The government has revised the gap between the two doses for the Oxford-AstraZeneca’s Covishield, manufactured by the Serum Institute of India (SII), to 12-16 weeks. However, the interval for the second dose of Bharat Biotech’s Covaxin remains unchanged at four weeks.

Prime Minister Narendra Modi launched the nationwide vaccination drive on January 16, with healthcare workers at the frontline of India’s COVID-19 battle getting their first jabs. The next phase started on March 1 for people over 60 years and those aged 45 and above with specified comorbid conditions. From April 1, the drive was expanded to include all aged 45 and above. The government decided to expand the vaccination drive by allowing everyone above 18 to be vaccinated from May 1.

Some major relevant developments:

- Drug firm Zydus Cadila has received an order to supply one crore doses of its COVID-19 vaccine, ZyCoV-D, to the Indian government at Rs 265 per dose, it said on November 8. "Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world's first Plasmid DNA Vaccine, to the Government of India at Rs 265 per dose and the needle-free applicator being offered at Rs 93 per dose, excluding GST," the pharma firm said in a regulatory filing.

- People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study published in Scientific Reports journal on the day. A team led by researchers at the University of Montreal in Canada found that these antibodies were also effective against the Delta variant.

- Scientists have developed a new protein-based vaccine candidate for COVID-19 that they say is much easier to produce and does not need refrigeration. The research team at Boston Children's Hospital, US, noted that currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries.

- Union Health Minister Dr Mansukh Mandaviya has appreciated the steps taken by Lieutenant Governor of Puducherry Tamilisai Soundararajan to encourage people to get vaccinated by visiting their houses.

- The Supreme Court said on the day that it would hear on November 29 a plea seeking directions for disclosure of data on clinical trials of COVID-19 vaccines as also on post-jab cases. The apex court had earlier in August asked the Centre, Bharat Biotech, SII, and others to respond to the plea, which sought directions to also disclose post-vaccination data regarding adverse events.

- China's military on Monday gifted health materials, including 3,00,000 COVID-19 vaccine doses, to the Nepal Army, an official statement said. The People's Liberation Army (PLA) handed over the Nepal Army with 3 lakh doses of Vero Cell vaccines, 100 units of oxygen concentrators and other health materials, according to a press release issued by Nepal Army headquarters.

Vaccination count for states/UTs:
StatesTotal Beneficiaries
Andhra Pradesh 5,51,18,556
Arunachal Pradesh 13,33,723
Assam 2,91,66,140
Bihar7,09,70,930
Chandigarh14,90,923
Chhattisgarh2,26,23,946
Delhi2,08,21,270
Goa22,15,350
Gujarat7,20,05,771
Haryana2,62,48,784
Himachal Pradesh94,43,700
Jammu and Kashmir1,52,75,757
Jharkhand2,13,49,793
Karnataka 6,67,32,314
Kerala3,99,79,891
Madhya Pradesh7,20,07,638
Maharashtra9,96,69,139
Odisha3,91,55,676
Punjab2,24,60,386
Rajasthan6,31,77,096
Tamil Nadu 5,96,63,119
Telangana3,38,31,667
Uttar Pradesh13,42,11,190
Uttarakhand 1,15,60,681
West Bengal8,18,08,143
(With inputs from PTI)
Moneycontrol News
first published: Nov 9, 2021 09:33 am
Sections
ISO 27001 - BSI Assurance Mark